Subscribe

Big Tree Group, Inc. (BIGG)

USD0.00 +0.00 (+0.00%)
CN OTC Healthcare Medical - Healthcare Information Services
Address 431 Fairway Drive 33441
Shantou, FL, CN
CEO Xiu Huan Lin
IPO 1996-03-04
CIK 1097896 ISIN US0896951003

Explore sections of this company profile

Description

Big Tree Group, Inc. engages in the business of sourcing and distribution of toys and related products. It operates through its subsidiaries: Shantou Big Tree Toys Co. Ltd. (BT Shantou) and Big Tree International Co. Ltd. (BT Brunei). The BT Shantou provides various procurement services for international toy distributors and wholesalers, including identifying, evaluating, and engaging local manufacturers for supply of toys, as well as to arrange for original equipment manufacturing services in which local OEMs produce toy products to the specific specifications of customers. The BT Shantou developed a proprietary construction toy consisting of plastic pieces that can plug-in together to make a wide variety of objects, which refer to Big Tree Magic Puzzle (3D). The company was founded 1987 and is headquartered in Shantou, China.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD0.00 +0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
4.8K
Beta
2.65
Float Shares
14.59M
Free Float %
65.7%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.00% +0.00% +0.00% +0.00% +0.00% +0.00% +0.00% +0.00% -92.86% -94.74% -100.00%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (1 ratings, all time) Buy
Price Targets & DCF
Current price
0.00
DCF (Unlevered) 4.99 +4,990,554.7%
DCF (Levered) 2.45 +2,447,832.8%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM)
Rating 2024-06 Change
Strong Buy 0 0
Buy 0 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
2.86
Grey zone
Piotroski F-Score
6 / 9
Average
MOAT Score
2 / 10
No MOAT
Operational MOAT
✗ Below peers
  • Revenue growth Medical - Healthcare Information Services: +14.2%
    +17.2% Q2'14: -59.3% (vs Q2'13)
  • EPS growth Medical - Healthcare Information Services: +43.1%
    -68.8% Q2'14: -107.7% (vs Q2'13)
  • FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%
    +1.4% Q2'14: +20.2% (vs Q2'13)
  • EBIT margin Medical - Healthcare Information Services: +8.8%
    +4.0% Q2'14: -1.1% (vs Q2'13)
  • ROIC Medical - Healthcare Information Services: +5.2%
    +201.8% Q2'14: +44.1% (vs Q2'13)
  • Share dilution Medical - Healthcare Information Services: -0.1%
    +10.9% Q2'14: +23.8% (vs Q2'13)
  • Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×
    0.00× Q2'14: 0.00× (vs Q2'13)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (2.70) × ERP
WACC = 100% × Ke + 0% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 4.99 Current price: 0.00
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2023
actual
Dec 2024
actual
Dec 2025
actual
Revenue
6.12M
est.
10.90M
est.
17.20M
est.
EBITDA
952.1K
est.
1.70M
est.
2.68M
est.
EBIT
952.1K
est.
1.70M
est.
2.68M
est.
Net Income
-557.7K
est.
-223.1K
est.
est.
SGA
2.46M
est.
4.39M
est.
6.93M
est.
EPS
-0.05
est.
-0.02
est.
est.

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
735.7K
OE per share TTM
0.06
Owner's Yield
57,428.11%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
1.9%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
Total invested
Insider transactions (90d)
0
Beneficial owners (>5%)
2
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 Jason Scott 7.63M 8.02% 7.63M 7.63M IN U.S. 2015-05-18
2 China Direct Investments, Inc.202307927 962.7K 9.72% 962.7K 962.7K 10.00 CO OR PLACE OF ORGANIZATION 2013-03-11

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
23.9K
Shares Outstanding
22.21M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2010 Wei Lin, Chief Executive Officer and Chairman of the Board of Directors 47.5K 47.5K 0.00%
2 2009 Wei Lin, Chief Executive Officer and Chairman of the Board of Directors 38.0K 38.0K 0.00%
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2012-10-30 DEF 14A
2012-01-20 PRE 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2020-01-29 15-12G
2017-04-10 SC 13G/A
2017-02-07 SC 13G/A
2016-08-04 SC 13G
2015-05-18 SC 13G
2015-03-24 SC 13G
2014-11-17 NT 10-Q
2014-09-23 SC 13G/A
2014-09-05 8-K
2014-08-14 10-Q

Executive team

NameTitleCompensationGender
Xiuhuan Lin Chairman and Chief Executive Officer male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits